Pharming Group N.V. (PHAR)

Pharming Group Income Statement

Financials in millions EUR. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019	2018
Revenue	245.32	205.62	198.87	212.17	189.39	135.13
Revenue Growth (YoY)	19.30%	3.39%	-6.27%	12.03%	40.15%	-
Cost of Revenue	25.21	17.56	21.14	23.54	23.93	22.18
Gross Profit	220.1	188.06	177.73	188.64	165.46	112.95
Selling, General & Admin	179.93	131.82	96.42	75.69	65.92	46.76
Research & Development	68.91	52.53	70.37	38.52	31.79	28.88
Other Operating Expenses	-23.35	-14.52	-2.62	-1.83	-0.49	-0.68
Operating Expenses	225.49	169.83	164.17	112.38	97.22	74.96
Operating Income	-5.39	18.23	13.56	76.26	68.25	37.99
Other Expense / Income	6.63	3.25	-9.52	32.16	15.94	37.14
Pretax Income	-12.01	14.99	23.08	44.09	52.3	0.86
Income Tax	-1.46	1.31	7.08	6.35	11.75	-24.14
Net Income	-10.55	13.67	16	37.75	40.56	24.99
Net Income Growth	-	-14.52%	-57.62%	-6.93%	62.27%	-
Shares Outstanding (Basic)	659	649	639	638	638	-
Shares Change	1.61%	1.55%	0.12%	-	-	-
EPS (Basic)	-0.16	0.21	0.25	0.58	0.65	0.41
EPS (Diluted)	-0.16	0.19	0.23	0.55	0.60	0.38
EPS Growth	-	-17.39%	-58.18%	-8.33%	57.89%	-
Free Cash Flow	-18.74	21.08	27.1	78.97	71.5	38.01
Free Cash Flow Per Share	-0.28	0.33	0.42	1.24	1.12	-
Gross Margin	89.72%	91.46%	89.37%	88.91%	87.37%	83.59%
Operating Margin	-2.20%	8.87%	6.82%	35.94%	36.03%	28.12%
Profit Margin	-4.30%	6.65%	8.04%	17.79%	21.41%	18.50%
Free Cash Flow Margin	-7.64%	10.25%	13.63%	37.22%	37.75%	28.13%
Effective Tax Rate	-	8.76%	30.69%	14.40%	22.46%	-2816.34%
EBITDA	3.91	28.18	42.69	52.41	58.11	7.42
EBITDA Margin	1.60%	13.70%	21.47%	24.70%	30.68%	5.49%
Depreciation & Amortization	15.93	13.19	19.61	8.31	5.8	6.56
EBIT	-12.01	14.99	23.08	44.09	52.3	0.86
EBIT Margin	-4.90%	7.29%	11.60%	20.78%	27.62%	0.63%

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).